NOVO-NORDISK (NVO) Covered Calls

NOVO-NORDISK covered calls Novo-Nordisk A/S is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments: diabetes care and biopharmaceuticals.

You can sell covered calls on NOVO-NORDISK to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for NVO (prices last updated Wed 4:16 PM ET):

NOVO-NORDISK (NVO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
48.27 -0.35 48.17 48.35 1.0M 20 118B
Covered Calls For NOVO-NORDISK (NVO)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jun 15 48 1.30 47.05 2.0% 30.4%
Jul 20 48 1.90 46.45 3.3% 20.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Novo Nordisk AS engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the Diabetes Care and Biopharmaceuticals segments. The Diabetes Care segment deals with the research, development, manufacture, and marketing of products within the areas of insulin, glucagon-like-peptide 1 and related delivery systems, oral anti-diabetic products, and obesity. The Biopharmaceuticals segment handles the research, development, manufacture, and distribution of products within the areas of haemophilia, growth hormone, hormone replacement, inflammation and other therapy areas. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.